FDA recently granted Pentax approval to market a duodenoscope with fewer parts that need to be cleaned, according to an article on the Advisory Board website.
According to FDA, as many as 350 patients at 41 medical facilities across the globe were infected by or exposed to contaminated gastrointestinal scopes between 2010 and 2015.
Contaminated scopes had killed at least 35 patients in the United States from 2013 to January 2017.
FDA in 2013 started to collaborate with duodenoscope manufacturers Fujifilm, Olympus, and Pentax to address contamination risks.
AI Usage for Healthcare Facilities
Ground Broken on Pelican Valley Senior Living Modernization Project
All-Electric UCI Health – Irvine Hospital Set to Open
The Rising Strategic Value of Owner's Reps in Healthcare
Lawrence Group Designs Pair of Ignite Medical Resorts in Missouri